Opko Health OPK Diagnostics — Selling General And Administrative Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opko Health's diagnostics — selling general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Opko Health's diagnostics — selling general and administrative expense?
- Opko Health (OPK) reported diagnostics — selling general and administrative expense of $26.15M in Q1 2026.
- How has Opko Health's diagnostics — selling general and administrative expense changed year-over-year?
- Opko Health's diagnostics — selling general and administrative expense decreased by 31.1% year-over-year, from $37.96M to $26.15M.
- What is the long-term trend for Opko Health's diagnostics — selling general and administrative expense?
- Over 3 years (2022 to 2025), Opko Health's diagnostics — selling general and administrative expense has grown at a -23.1% compound annual growth rate (CAGR), from $284.39M to $129.3M.
- What does diagnostics — selling general and administrative expense mean?
- Includes all indirect costs associated with operating the diagnostics segment, such as sales force commissions, marketing, administrative salaries, and corporate overhead. This metric reflects the operational intensity required to support and grow the diagnostics business. Managing these expenses is critical for achieving operating leverage within the segment.